 |
|
|
| |
Long-Acting Cabotegravir + Rilpivirine in Older Adults: Pooled Phase 3 Week 96 Results
|
| |
| |
AIDS 2022 July 29 - Aug 1 Montreal
Emilie R. Elliot1, Ronald D'Amico2, Andrew Clark1, Joseph W. Polli2, Louise Garside3, Jeremy Roberts4, Paul D. Benn1, Susan L. Ford5, Simon Vanveggel6,
Bryan Baugh7, Jean van Wyk1
1ViiV Healthcare, Brentford, United Kingdom; 2ViiV Healthcare, Research Triangle Park, NC, United States; 3PHASTAR, Macclesfield, United Kingdom; 4GlaxoSmithKline, Mississauga, ON, Canada; 5GlaxoSmithKline, Research Triangle Park, NC, United States; 6Janssen Research & Development, Beerse, Belgium; 7Janssen Research & Development, Titusville, NJ, United States
|
| |
|
|
|
|
|
